Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Early improvement in cardiac tissue perfusion due to mesenchymal stem cells.

Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR, Hatzistergos KE, Oskouei BN, Zimmet JM, Young RG, Heldman AW, Lardo AC, Hare JM.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2002-11. doi: 10.1152/ajpheart.00762.2007. Epub 2008 Feb 29.

2.

Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches.

Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML.

J Appl Physiol (1985). 2007 Jun;102(6):2104-11. Epub 2007 Mar 8.

3.

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators.

Eur Heart J. 2006 Dec;27(23):2775-83. Epub 2006 Nov 10.

PMID:
17098754
4.

Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction.

Zhang Y, Takagawa J, Sievers RE, Khan MF, Viswanathan MN, Springer ML, Foster E, Yeghiazarians Y.

Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1187-92. Epub 2006 Oct 6.

5.

Cardiac cell therapy--mixed results from mixed cells.

Rosenzweig A.

N Engl J Med. 2006 Sep 21;355(12):1274-7. No abstract available.

6.

Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators.

N Engl J Med. 2006 Sep 21;355(12):1210-21.

7.

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K.

N Engl J Med. 2006 Sep 21;355(12):1199-209.

8.

Biomaterials for the treatment of myocardial infarction.

Christman KL, Lee RJ.

J Am Coll Cardiol. 2006 Sep 5;48(5):907-13. Epub 2006 Aug 17. Review.

9.

Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling.

Uemura R, Xu M, Ahmad N, Ashraf M.

Circ Res. 2006 Jun 9;98(11):1414-21. Epub 2006 May 11.

10.

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F.

Lancet. 2006 Jan 14;367(9505):113-21.

PMID:
16413875
11.

Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment.

Dawn B, Bolli R.

Basic Res Cardiol. 2005 Nov;100(6):494-503. Review.

12.

Optimizing techniques for tracking transplanted stem cells in vivo.

Brazelton TR, Blau HM.

Stem Cells. 2005 Oct;23(9):1251-65. Epub 2005 Aug 18.

13.

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction.

Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM.

Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11474-9. Epub 2005 Aug 1.

14.

Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography.

Springer ML, Sievers RE, Viswanathan MN, Yee MS, Foster E, Grossman W, Yeghiazarians Y.

Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1307-14. Epub 2005 May 20.

15.

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ.

Nat Med. 2005 Apr;11(4):367-8. No abstract available.

PMID:
15812508
16.

Intracardiac transplantation of a mixed population of bone marrow cells improves both regional systolic contractility and diastolic relaxation.

Thompson RB, van den Bos EJ, Davis BH, Morimoto Y, Craig D, Sutton BS, Glower DD, Taylor DA.

J Heart Lung Transplant. 2005 Feb;24(2):205-14.

PMID:
15701439
17.

Clinical applications of stem cells for the heart.

Wollert KC, Drexler H.

Circ Res. 2005 Feb 4;96(2):151-63. Review.

18.

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.

Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P.

Circ Res. 2005 Jan 7;96(1):127-37. Epub 2004 Nov 29.

19.

Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies.

Losordo DW, Dimmeler S.

Circulation. 2004 Jun 8;109(22):2692-7. Review. No abstract available.

20.

Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction.

Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ.

Tissue Eng. 2004 Mar-Apr;10(3-4):403-9.

PMID:
15165457

Supplemental Content

Support Center